The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells

MLA

Adrienne Bolden, et al. “The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.” PPAR Research, vol. 2012, Jan. 2012. EBSCOhost, https://doi.org/10.1155/2012/929052.

APA

Adrienne Bolden, Lynikka Bernard, Danielle Jones, Tunde Akinyeke, & LaMonica V. Stewart. (2012). The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells. PPAR Research, 2012. https://doi.org/10.1155/2012/929052

Chicago

Adrienne Bolden, Lynikka Bernard, Danielle Jones, Tunde Akinyeke, and LaMonica V. Stewart. 2012. “The PPAR Gamma Agonist Troglitazone Regulates Erk 1/2 Phosphorylation via a PPARγ-Independent, MEK-Dependent Pathway in Human Prostate Cancer Cells.” PPAR Research 2012 (January). doi:10.1155/2012/929052.